ELABS — Elliptic Laboratories ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK1.53bn
- NOK1.44bn
- NOK68.32m
Annual cashflow statement for Elliptic Laboratories ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | NAS | NAS | NAS | NAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17 | -15.6 | -13.1 | -39.3 | -46.9 |
| Depreciation | |||||
| Non-Cash Items | 5.19 | 5.66 | 11 | 13.8 | 10.4 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.9 | -2.22 | -17 | 1.45 | -17.6 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.3 | -6.68 | -10.8 | -12.8 | -37.8 |
| Capital Expenditures | -9.38 | -15.1 | -17.6 | -23.3 | -26 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -9.38 | -15.1 | -17.6 | -23.3 | -26 |
| Financing Cash Flow Items | -2.75 | -10.6 | -9.19 | -0.571 | -0.588 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 38.4 | 87.2 | 147 | -4.26 | 0.963 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.7 | 65.4 | 118 | -39.9 | -62.6 |